View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline.
Authors: Mounzer, Karam1 (AUTHOR), Slim, Jihad2 (AUTHOR), Ramgopal, Moti3 (AUTHOR), Hedgcock, Malcolm4 (AUTHOR), Bloch, Mark5 (AUTHOR), Santana, Jorge6 (AUTHOR), Aizen, Keith7 (AUTHOR), Zhang, Xu8 (AUTHOR), Sklar, Peter9 (AUTHOR), Montezuma-Rusca, Jairo M9 (AUTHOR), Segal-Maurer, Sorana10 (AUTHOR)
Source: Open Forum Infectious Diseases. Nov2025, Vol. 12 Issue 11, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofaf615